Mads Vargas Damgaard

Mads Vargas Damgaard

Research assistant

ORCID: 0000-0001-8488-2298

Publication year:
All
1 - 4 out of 4Page size: 10
  1. 2022
  2. Published

    A randomized placebo-controlled trial of nicotinamide riboside and pterostilbene supplementation in experimental muscle injury in elderly individuals

    Jensen, J. B., Dollerup, O. L., Møller, A. B., Billeskov, T. B., Kellezi, Emilie Dalbram, Chubanava, Sabina, Damgaard, Mads Vargas, Dellinger, R. W., Trošt, K., Moritz, Thomas, Ringgaard, S., Møller, N., Treebak, Jonas Thue, Farup, J. & Jessen, N., 2022, In: JCI insight. 7, 19, 15 p., e158314.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Intravenous nicotinamide riboside elevates mouse skeletal muscle NAD+ without impacting respiratory capacity or insulin sensitivity

    Damgaard, Mads Vargas, Nielsen, Thomas Svava, Basse, A. L., Chubanava, Sabina, Trost, K., Moritz, Thomas, Dellinger, R. W., Larsen, Steen & Treebak, Jonas Thue, 2022, In: iScience. 25, 2, 21 p., 103863.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Protocol for qPCR analysis that corrects for cDNA amplification efficiency

    Damgaard, Mads Vargas & Treebak, Jonas Thue, 2022, In: STAR Protocols. 3, 3, 11 p., 101515.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Pterostilbene Fails to Rescue Insulin Secretion and Sensitivity in Multiple Murine Models of Diabetes

    Damgaard, Mads Vargas, Jepsen, Sara Lind, Ashcroft, Stephen Paul, Holst, Jens Juul & Treebak, Jonas Thue, 2022, In: Nutrients. 14, 18, 11 p., 3741.

    Research output: Contribution to journal › Journal article › Research › peer-review

ID: 186177316